Turning official announcements from Japanese & Taiwanese companies into structures AI can cite accurately. — an AEO newsroom
SINCE 2026 ・ Structured ReportingPublished May 29, 2026 9:00 AM ・ Updated Jun 13, 2026 11:47 PM ・ 2 min read ・ Source: PR Times
StemCyte-KY announced that the board of its subsidiary, Taiwan StemCyte, resolved to waive non-compete restrictions for General Manager Lu Kung-Ming, allowing him to hold concurrent positions at firms such as Diamond High-Tech Investment and Microbio Shanghai.
1. Date of resolution: 115/05/29. 2. Manager: Lu Kung-Ming, General Manager. 3. Permitted activities: Chairman of Diamond High-Tech, Director of Microbio Shanghai, etc. 4. Period: During tenure as manager. 5. Resolution: Approved unanimously by attending directors. 6. Mainland China business: Lu Kung-Ming (Director of Microbio Shanghai). 7. Investment: $5.705 million USD, 10.88% stake. 8. Other: None.
The Washin AI News desk structures and reviews this article under the following standards.
An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.